Sen. Kim Introduces NIH Clinical Trial Integrity Act
Bill Intros-Senate
Copyright © Targeted News Service, 2026
Copyright © Targeted News Service, 2026
2026-01-24
Bailey Malota
WASHINGTON, Jan. 24 -- Sen. Andy Kim, D-NJ, has introduced the NIH Clinical Trial Integrity Act, aimed at enhancing diversity within clinical trials funded by the National Institutes of Health (NIH). The proposed legislation mandates that NIH-funded research organizations outline clear strategies for recruiting and retaining a diverse array of participants, reflecting the demographics of the disease or condition under investigation.
In light of ongoing discrepancies in clinical tria . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Jan. 24 -- Sen. Andy Kim, D-NJ, has introduced the NIH Clinical Trial Integrity Act, aimed at enhancing diversity within clinical trials funded by the National Institutes of Health (NIH). The proposed legislation mandates that NIH-funded research organizations outline clear strategies for recruiting and retaining a diverse array of participants, reflecting the demographics of the disease or condition under investigation.
In light of ongoing discrepancies in clinical tria . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com